Home News About Us Contact Contributors Disclaimer Privacy Policy Help FAQ

Quick Search
My eDoc
Session History
Support Wiki
Direct access to
document ID:

          Institute: MPI für Herz- und Lungenforschung (W. G. Kerckhoff Institut)     Collection: Publikationen des W. G. Kerckhoff-Instituts     Display Documents

ID: 559764.0, MPI für Herz- und Lungenforschung (W. G. Kerckhoff Institut) / Publikationen des W. G. Kerckhoff-Instituts
Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo
Authors:Yang, J.; Li, X.; Al-Lamki, R. S.; Southwood, M.; Zhao, J.; Lever, A. M.; Grimminger, F.; Schermuly, R. T.; Morrell, N. W.
Title of Journal:Circ Res
Issue / Number:2
Start Page:252
End Page:62
Audience:Not Specified
Abstract / Description:RATIONALE: Mutations in the bone morphogenetic protein type II receptor (BMPR-II) are responsible for the majority of cases of heritable pulmonary arterial hypertension (PAH). Mutations lead to reduced Smad1/5-driven expression of inhibitor of DNA binding protein 1 (Id1) and loss of the growth suppressive effects of BMPs. The impact of existing PAH therapies on BMP signaling is lacking. OBJECTIVE: Because prostacyclin analogues are effective treatments for clinical PAH, we hypothesized that these agents enhance Smad1/Id1 signaling. METHODS AND RESULTS: Iloprost alone induced Id1 expression in human pulmonary artery smooth muscle cells (PASMCs), an effect that was independent of Smad1/5 activation but dependent on a cAMP-responsive element in the Id1 promoter. In addition, iloprost and treprostinil enhanced BMP-induced phosphorylation of Smad1/5 and Id1 expression in a cAMP-dependent manner. The mechanism involved suppression of inhibitory Smad, Smad6. Furthermore, iloprost rescued the deficit in Smad1/5 phosphorylation and Id gene expression in PASMCs harboring mutations in BMPR-II and restored growth suppression to BMP4 in mutant PASMCs. We confirmed a critical role for Id1 in PASMC proliferation. Reduced expression of Id1 was observed in concentric intimal lesions of heritable PAH cases. In the monocrotaline rat model of PAH, associated with reduced BMPR-II expression, we confirmed that treprostinil inhibited smooth muscle cell proliferation and prevented progression of PAH while enhancing Smad1/5 phosphorylation and Id1 gene expression. CONCLUSIONS: Prostacyclin analogues enhance Id1 expression in vitro and in vivo and restore deficient BMP signaling in BMPR-II mutant PASMCs.
Free Keywords:Animals; Antihypertensive Agents/*pharmacology; Bone Morphogenetic Protein 4/metabolism; Bone Morphogenetic Protein Receptors, Type II/genetics; Cell Proliferation/*drug effects; Cells, Cultured; Cyclic AMP/metabolism; Cyclic AMP-Dependent Protein Kinases/metabolism; Disease Models, Animal; Epoprostenol/analogs & derivatives/*pharmacology; Humans; Hypertension, Pulmonary/chemically induced/*drug; therapy/genetics/metabolism/pathology; Iloprost/pharmacology; Inhibitor of Differentiation Protein 1/genetics/*metabolism; Male; Monocrotaline; Muscle, Smooth, Vascular/*drug effects/metabolism/pathology; Mutation; Myocytes, Smooth Muscle/*drug effects/metabolism/pathology; Phosphorylation; Promoter Regions, Genetic; Pulmonary Artery/drug effects/metabolism/pathology; RNA Interference; Rats; Rats, Sprague-Dawley; Smad Proteins/genetics/*metabolism; Smad1 Protein/metabolism; Smad5 Protein/metabolism; Smad6 Protein/metabolism; Transfection; Up-Regulation
External Publication Status:published
Document Type:Article
Communicated by:N. N.
Affiliations:MPI für physiologische und klinische Forschung
External Affiliations:Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's and Papworth Hospital, Cambridge CB20QQ, UK.
Identifiers:ISSN:1524-4571 (Electronic) 0009-7330 (Linking)
The scope and number of records on eDoc is subject to the collection policies defined by each institute - see "info" button in the collection browse view.